Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin for Post-operative Pancreatitis Prevention
NCT05109143Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Oct 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of indomethacin in pancreatitis, sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Post-operative Pancreatitis at 30 days. Started Oct 2020; status: completed.
02
Drugs
indomethacin
03
Conditions
pancreatitis
Beyond the preview
Go deeper on NCT05109143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109143.